ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,729Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 131

$1.21M Total Retail Price of All Prescriptions

Rank: 2 out of 131

627 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 627 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 627 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 19,418 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $68 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 1,301 1,291 1 3
METOPROLOL SUCCINATE 723 703 2 10
NEXIUM 645 644 3 16
AMLODIPINE BESYLATE 575 574 4 2
POTASSIUM CHLORIDE 563 560 5 29
METOPROLOL TARTRATE 494 468 6 7
ISOSORBIDE MONONITRATE ER 489 489 7 45
SIMVASTATIN 417 415 8 1
ZOLPIDEM TARTRATE 417 414 8 15
NAMENDA 384 384 10 26
ENALAPRIL MALEATE 383 378 11 18
TRAMADOL HCL 375 366 12 31
PLAVIX 365 360 13 36
DIGOXIN 318 318 14 49
CLOPIDOGREL 315 310 15 28
OMEPRAZOLE 299 299 16 4
NITROGLYCERIN PATCH 298 298 17 123
QUETIAPINE FUMARATE 246 246 18 43
CRESTOR 239 232 19 19
ATORVASTATIN CALCIUM 235 235 20 11
TAMSULOSIN HCL 209 207 21 24
JANUVIA 206 206 22 32
ESCITALOPRAM OXALATE 203 198 23 63
DONEPEZIL HCL 201 201 24 17
METFORMIN HCL 199 196 25 8
CLOTRIMAZOLE-BETAMETHASONE 197 193 26 61
WARFARIN SODIUM 193 193 27 9
CREON 192 192 28 153
CLONIDINE HCL 188 188 29 72
CARVEDILOL 179 179 30 25
LEVOFLOXACIN 178 175 31 96
MECLIZINE HCL 176 176 32 79
LEVOTHYROXINE SODIUM 173 173 33 5
GABAPENTIN 171 171 34 20
COUMADIN 168 168 35 205
GLIPIZIDE 166 161 36 68
LOSARTAN POTASSIUM 156 156 37 21
LIDODERM 155 155 38 75
LOVAZA 155 155 38 41
VOLTAREN 154 152 40 59
SILVER SULFADIAZINE 149 140 41 105
LIPITOR 148 148 42 98
DIOVAN 131 131 43 30
SYNTHROID 128 128 44 71
SEROQUEL 116 116 45 91
CARBIDOPA-LEVODOPA 110 101 46 60
SERTRALINE HCL 109 109 47 27
AMMONIUM LACTATE 107 107 48 76
KLOR-CON 10 103 101 49 186
FAMOTIDINE 99 91 50 44
HYDROCHLOROTHIAZIDE 98 98 51 12
RANEXA 97 97 52 203
BYSTOLIC 95 94 53 118
ADVAIR DISKUS 92 90 54 33
SPIRONOLACTONE 92 92 54 86
DICYCLOMINE HCL 89 89 56 260
LISINOPRIL 85 77 57 6
HYDROCODONE BIT-IBUPROFEN 81 81 S3 58 272
AZITHROMYCIN 79 75 59 38
ATENOLOL 79 78 59 14
TRAZODONE HCL 79 79 59 40
CITALOPRAM HBR 76 64 62 22
SOLARAZE 76 74 62 132
PROCTOZONE-HC 76 76 62 190
LEXAPRO 74 74 65 171
LOPERAMIDE 72 71 66 283
FINASTERIDE 71 71 67 77
KLOR-CON M10 71 71 67 164
MIRTAZAPINE 70 66 69 34
RISPERIDONE 69 65 70 42
PREDNISONE 68 68 71 51
DETROL LA 67 67 72 192
PROCHLORPERAZINE MALEATE 66 66 73 294
ALCOHOL SWABS 62 62 74 222
LEVETIRACETAM 61 59 75 37
NITROSTAT 60 60 76 302
AVODART 59 59 77 172
ACETAMINOPHEN-CODEINE 59 56 S3 77 201
ZETIA 58 58 79 109
ACTOS 55 55 80 202
LOSARTAN-HYDROCHLOROTHIAZIDE 54 54 81 58
EXELON 54 54 81 94
LACTULOSE 54 49 81 54
SSD 53 53 84 115
CIPROFLOXACIN HCL 52 48 85 74
ALENDRONATE SODIUM 50 50 86 23
HYDROCODONE-ACETAMINOPHEN 50 50 S3 86 13
RAMIPRIL 50 50 86 73
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.